Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Animalcare GroupSTU:WQ7 77 EV-to-FCF is 32.34 as of Jul. 25, 2026, which is 62% above its 10-year median of 19.92. GuruFocus rates STU:WQ7 with a GF Score™ of 77/100 and a GF Value™ of €2.85 (Fairly Valued). The stock has 7 warning signs investors should review. Among 568 Drug Manufacturers companies, Animalcare Group ranks worse than 62.15% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Animalcare Group's Enterprise Value is €283.8 Mil.
Animalcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €8.8 Mil. Therefore, Animalcare Group's EV-to-FCF for today is 32.34.
The historical rank and industry rank for Animalcare Group's EV-to-FCF or its related term are showing as below:
STU:WQ7'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.07 Med: 19.92 Max: 232.4
Current: 32.08
During the past 13 years, the highest EV-to-FCF of Animalcare Group was 232.40. The lowest was 10.07. And the median was 19.92.
STU:WQ7's EV-to-FCF is ranked worse than 62.15% of 568
companies
in the Drug Manufacturers industry
Industry Median: 21.015
vs STU:WQ7: 32.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Animalcare Group's PE Ratio (TTM) for today is calculated as:
Animalcare Group's share price for today is €3.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Animalcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.085.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Animalcare Group EV-to-FCF Related Terms
Animalcare Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Animalcare Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Animalcare Group EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Animalcare Group's EV-to-FCF falls into.
Animalcare Group's current Enterprise Value is €283.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Animalcare Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €8.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group (STU:WQ7) has a EV-to-FCF of 32.34 as of Jul. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Animalcare Group and its competitors. This is 62% above median its historical median of 19.92. Over the past decade, Animalcare Group's EV-to-FCF has ranged from 10.07 to 232.40. According to the industry distribution chart, Animalcare Group ranks #353 out of 568 companies in the Drug Manufacturers industry, placing it in the top 62.1%.
Is Animalcare Group's EV-to-FCF too high?
Animalcare Group's current EV-to-FCF of 32.34 is 62% above median its 10-year median of 19.92. Over the past 10 years, this metric has ranged from a low of 10.07 to a high of 232.40. The Drug Manufacturers industry median EV-to-FCF is 21.02. Animalcare Group's value of 32.34 is 53.9% above this industry median. Based on the distribution chart, Animalcare Group ranks #353 out of 568 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Animalcare Group has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Animalcare Group's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Animalcare Group ranks #353 out of 568 companies for EV-to-FCF. This places Animalcare Group in the lower half of its industry. The industry median EV-to-FCF is 21.02. Animalcare Group's value of 32.34 is 53.9% above this benchmark. Historically, Animalcare Group's own EV-to-FCF has ranged from 10.07 to 232.40 over the past decade. While the company's 10-year median is 19.92 vs. the industry median of 21.02, Animalcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 21.02, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Animalcare Group's current EV-to-FCF of 32.34 is 53.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Animalcare Group and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 21.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Animalcare Group's current EV-to-FCF is 32.34, which is 62% above median its own 10-year median of 19.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Animalcare Group stock overvalued right now?
Based on GuruFocus' analysis, Animalcare Group (STU:WQ7) is currently considered Fairly Valued. The stock's GF Value™ is €2.85, compared to a current price of €3.00 — trading 5.3% above its estimated fair value. The current EV-to-FCF is 32.34, which is 62% above median its 10-year median of 19.92 and 53.9% above the Drug Manufacturers industry median of 21.02. Animalcare Group's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Animalcare Group (STU:WQ7), the current EV-to-FCF is 32.34 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Animalcare Group (STU:WQ7) Overvalued in 2026?
Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued.
The current stock price of €3.00 is trading 5.3% above its estimated GF Value™ of €2.85.
GuruFocus considers Animalcare Group to be Fairly Valued.
Key valuation signals for STU:WQ7:
EV-to-FCF: 32.34 (62% above median its 10-year median of 19.92)
GF Value™: €2.85 vs. price of €3.00 (5.3% above fair value)
Industry Position: 53.9% above the Drug Manufacturers median (#353 of 568)
No single metric tells the full story. See the STU:WQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
77GF Score
Get the complete analysis for STU:WQ7
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WQ7 has been successfully added to your 
